Archive for the 'Pharma' Category
All information about Pharma, Pharma Latest News
December 11th, 2009 | Category Pharma |
The U.K. has unveiled a tax incentive plan that would from 2013 offer companies a 10 percent tax break on revenues resulting from patents filed there. U.K.-based GlaxoSmithKline likes the sound of that. “The patent box is exactly the sort of active, long-term and creative support that we need…
December 11th, 2009 | Category Pharma |
A popular type of osteoporosis drug may reduce women’s risk of developing breast cancer, according to two
December 11th, 2009 | Category Pharma |
Companies like IMS and Verispan have built major businesses by collecting data on physician prescribing habits and selling it to drugmakers. Pharma companies
December 10th, 2009 | Category Pharma |
Pfizer will extend its MAINTAIN™ (Medicines Assistance for Those who Are in Need) patient assistance program for an additional year, through December 31, 2010. In addition to the more than 70 Pfizer primary care medicines currently available through MAINTAIN, Pfizer will extend the benefits of MAINTAIN to many legacy Wyeth…
December 10th, 2009 | Category Pharma |
While most marketers have accepted that nearly all physicians are online today, the more difficult part is figuring out where to find these physicians on the World Wide Web. Finding the right promotional mix for connecting with physicians can be a challenging proposition, as physicians use third-party sites – such…
December 10th, 2009 | Category Pharma |
Pfizer is suing India’s Dr Reddy’s Laboratories in a Delaware federal court over a proposed generic version of the blockbuster cholesterol med Lipitor, according to Livemint . Dr Reddy’s notified Pfizer in October that it was seeking FDA approval for a generic version of the drug. The last-to-expire patent…
December 10th, 2009 | Category Pharma |
A top Ranbaxy executive says the company will launch a generic version of Astellas Pharma’s urinary disorders
December 10th, 2009 | Category Pharma |
Earlier this week, Bernstein Research analyst Dr. Tim Anderson said in a letter that Eli Lilly was among three Big Pharma companies facing the biggest patent losses over the next few years. Between 2011 and 2014, drugs like Zyprexa, Cymbalta, Gemzar and Evista will all go off-patent. When Lilly…
December 10th, 2009 | Category Pharma |
The SEC is investigating four pharma deals as part of a larger
December 10th, 2009 | Category Pharma |
Adult prescription drug expenditure doubled from 1996 to 2006, according to a report released by the Agency for Healthcare Research and Quality.